FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/02/040653 [Registered on: 28/02/2022] Trial Registered Prospectively
Last Modified On: 24/02/2022
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Cosmeceuitcal ]  
Study Design  Single Arm Study 
Public Title of Study   Safety and efficacy assessment of Product on skin 
Scientific Title of Study   To evaluate the in-vivo efficacy and safety of a hair care formulation in terms of reduction in Hair Fall and Anti-dandruff effect on healthy male & female subjects 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
XXX-7I05-KD-JR22; Version: Final 01; 08/02/2022  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Raji Patil 
Designation  Investigator 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  Kohinoor Estate, 3rd Floor, Sun Mill Compound, Lower Parel West, Mumbai. Mumbai (Suburban) MAHARASHTRA 400013 India

Mumbai
MAHARASHTRA
400013
India 
Phone  02243349191  
Fax    
Email  raji@mascotspincontrol.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Raji Patil 
Designation  Investigator 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  Kohinoor Estate, 3rd Floor, Sun Mill Compound, Lower Parel West, Mumbai. Mumbai (Suburban) MAHARASHTRA 400013 India

Mumbai
MAHARASHTRA
400013
India 
Phone  02243349191  
Fax    
Email  raji@mascotspincontrol.in  
 
Details of Contact Person
Public Query
 
Name  Mr Mohit Lalvani 
Designation  Study Director 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  Kohinoor Estate, 3rd Floor, Sun Mill Compound, Lower Parel West, Mumbai. Mumbai (Suburban) MAHARASHTRA 400013 India

Mumbai
MAHARASHTRA
400013
India 
Phone  02243349191  
Fax    
Email  mohit@mascotspincontrol.in  
 
Source of Monetary or Material Support  
Mascot SpincontrolIndia pvt. Ltd. 
 
Primary Sponsor  
Name  Kama Ayurveda Pvt Ltd  
Address  3 K Commercial Circle, Jungpura Extension, New Delhi – 110014  
Type of Sponsor  Other [Indian FMCG] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  Not applicable 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Raji Patil  Mascot Spincontrol India Pvt. Ltd.   Kohinoor Estate, 3rd Floor, Sun Mill Compound, Lower Parel West, Mumbai Mumbai (Suburban) MAHARASHTRA
Mumbai
MAHARASHTRA 
02243349191

raji@mascotspincontrol.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethos- An Institutional Ethics committee (Mumbai)   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  having moderate to severe dandruff and hairfall 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Hair Oil 3: Product A  Approx. 2-4 ml of given product is to be applied on scalp and hair shaft thrice a week. for period of 28 days. 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  35.00 Year(s)
Gender  Both 
Details  1. Having moderate to severe hair fall.
2. Having Moderate to severe dandruff (where 0 is None, 1 is Slight, 2 is Mild, 3 is Moderate, 4
is Severe)
3. Suffering with hair thinning on subject assessment basis.
For female: Having at least shoulder length hair.
Having washed their hair with provided neutral shampoo, 48 hours before the first day of the
study with the provided nuetral shampoo.
Having untangled their hair at home, 3 hours prior coming to the site for observations, the first
day of the study.  
 
ExclusionCriteria 
Details  1. Small, red bumps on the scalp, neck, and shoulders (bumps may become crusty and ooze).
2. Subject having applied a product with an anti-hair fall claim (due to breakage)or anti dandruff claim in the 2 weeks preceding the start of the study.
3. Having surgery history on the scalp (micro transplants …)
4. In the previous 6 months, Having undergone the Minoxidil treatments, Antiandrogen medicine (cyproterone acetate, spironolactone, flutamide), Having undergone one of the following treatments known to : induce hair loss : retinoids, anti coagulants, anti-convulsive drugs, chemotherapy, beta-blocking agents, non steroidal anti inflammatory drugs, corticoids,Having modified her hormonal contraception.

5. In the previous 3 months, Having undergone a local or general anti hair loss treatment (Biotine, dexpanthenol, sulphur amino-acid, B6 vitamin, zinc), Having taken a food supplement with an anti hair loss claim, Having taken an iron based treatment
6. In the previous 15 days, Having applied a product with an anti hair loss claim (due to breakage) or anti dandruff claim 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Reduction in Hair Fall, Reduction in Anti-dandruff effect   T0, 14 days and 28 days  
 
Secondary Outcome  
Outcome  TimePoints 
Safety on skin  T0, 14 days and 28 days  
 
Target Sample Size   Total Sample Size="36"
Sample Size from India="36" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   03/03/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Objective: The objective of this study will be to evaluate in-vivo safety and efficacy of hair care formulation in terms of reduction in Hair Fall and Anti-dandruff effect on healthy female & male subjects

Duration of study: 35 days study (The study lasts 35 days including the 7 days conditioning phase and 28 days application period)

Kinetics: Screening (T-7 days), T0, T+14 days and T+28 days 

Population: 36 (18 Females & 18 Males) volunteers

The evaluation is performed using: 

1. Subject’s Self Evaluation, 

2. Dermatological Evaluation: Cosmetic Acceptability, 

3. Dermatological Evaluation: Efficacy 

4. Counting of fallen hair after standardized combing

 
Close